Literature DB >> 2461407

Distribution of substance P binding sites in guinea-pig heart and pharmacological effects of substance P.

D B Hoover1, J C Hancock.   

Abstract

The localization of substance P (SP) binding sites in guinea-pig heart was studied by in vitro autoradiography, and pharmacological effects of SP were examined with isolated heart preparations. Specific binding of [125I]SP was found in association with cardiac parasympathetic ganglia and some coronary arteries. No specific SP binding sites were associated with coronary veins, atria, ventricles, ascending aorta or pulmonary trunk. Local bolus injections of SP (2.5 and 25 nmol) caused a bradycardia which, in some preparations, was followed by a slight tachycardia. SP produced a prominent coronary vasodilator effect after basal perfusion pressure had been elevated by 1 microM vasopressin. The vasodilator response was probably mediated by the SP binding sites associated with the coronary arteries. Bradycardia might be elicited by binding of SP to the receptors present in the parasympathetic ganglia and subsequent release of acetylcholine. It is suggested that these effects of SP on the isolated heart could be of physiological significance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2461407     DOI: 10.1016/0165-1838(88)90093-8

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  9 in total

1.  Local cardiac effects of substance P: roles of acetylcholine and noradrenaline.

Authors:  H Chiao; R W Caldwell
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

2.  Role of substance P in viral myocarditis in mice.

Authors:  Yong Wang; Miho Shimada; Yawei Xu; Dayi Hu; Ryosuke Nishio; Akira Matsumori
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

3.  Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells.

Authors:  Giselle C Meléndez; Jianping Li; Brittany A Law; Joseph S Janicki; Scott C Supowit; Scott P Levick
Journal:  Cardiovasc Res       Date:  2011-09-09       Impact factor: 10.787

Review 4.  Substance P in heart failure: the good and the bad.

Authors:  Heather M Dehlin; Scott P Levick
Journal:  Int J Cardiol       Date:  2013-11-12       Impact factor: 4.164

5.  Innervation of the human cardiac conduction system at birth.

Authors:  L T Chow; S S Chow; R H Anderson; J A Gosling
Journal:  Br Heart J       Date:  1993-05

6.  Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.

Authors:  A Roccon; D Marchionni; D Nisato
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

7.  Increased susceptibility to cardiovascular effects of dihydrocapcaicin in resuscitated rats. Cardiovascular effects of dihydrocapsaicin.

Authors:  Keld Fosgerau; Giuseppe Ristagno; Magdalena Jayatissa; Mads Axelsen; Jacob W Gotfredsen; Uno J Weber; Lars Køber; Christian Torp-Pedersen; Charlotte Videbaek
Journal:  BMC Cardiovasc Disord       Date:  2010-08-31       Impact factor: 2.298

8.  Substance P Receptor in the Rat Heart and Regulation of Its Expression in Long-Term Diabetes.

Authors:  Magdalena Chottova Dvorakova; Eliska Mistrova; Renate Paddenberg; Wolfgang Kummer; Jana Slavikova
Journal:  Front Physiol       Date:  2018-07-13       Impact factor: 4.566

9.  Neurokinin-3 receptor activation selectively prolongs atrial refractoriness by inhibition of a background K+ channel.

Authors:  Marieke W Veldkamp; Guillaume S C Geuzebroek; Antonius Baartscheer; Arie O Verkerk; Cees A Schumacher; Gedeon G Suarez; Wouter R Berger; Simona Casini; Shirley C M van Amersfoorth; Koen T Scholman; Antoine H G Driessen; Charly N W Belterman; Antoni C G van Ginneken; Joris R de Groot; Jacques M T de Bakker; Carol Ann Remme; Bas J Boukens; Ruben Coronel
Journal:  Nat Commun       Date:  2018-10-19       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.